BioStem Technologies (BSEM) Earnings Date, Estimates & Call Transcripts 13.49 +1.45 (+12.08%) (As of 06:38 PM ET) Add Share Share Earnings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest BioStem Technologies Latest Earnings SummaryLatest Earnings DateNov. 12EstimatedActual EPS (Nov. 12) 0.32 Beat By 0.01 Consensus EPS (Nov. 12) 0.31 BioStem Technologies issued Q3 2024 earnings on November 12, 2024, reporting an EPS of 0.32, which topped analysts' consensus estimates of 0.31 by 0.01. Quarterly revenue was reported to be 82.56 million, above the consensus estimate of 78.22 million. With a trailing EPS of 0.68 and a P/E Ratio of 19.84, BioStem Technologies' earnings are expected to grow 62.41% next year, from 1.41 to 2.29 per share. Conference Call TranscriptConference Call Audio Get BioStem Technologies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioStem Technologies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBSEM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BSEM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! BioStem Technologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 202410.740.740.74Q2 202410.770.770.77Q3 202410.360.360.36Q4 202410.370.370.37FY 202442.242.242.24Q1 202510.790.790.79Q2 202510.800.800.80Q3 202510.800.800.80Q4 202510.810.810.81FY 202543.203.203.20Q1 202610.520.520.52Q2 202610.570.570.57Q3 202610.610.610.61 BioStem Technologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks11/12/2024-0.310.32+0.010.3278.22M82.56M 8/12/2024Q2 20240.120.30+0.180.3043.99M74.49M 5/14/2024Q1 20240.740.20 -0.540.2012.70M41.90M4/1/2024Q4 2023--0.14 -0.14-0.1411.40M11.44M11/13/2023Q3 2023-0.180.03+0.210.031.39M3.60M BioStem Technologies Earnings - Frequently Asked Questions When did BioStem Technologies announce their last quarterly earnings? BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on BSEM's earnings history. Did BioStem Technologies beat their earnings estimates last quarter? In the previous quarter, BioStem Technologies (OTCMKTS:BSEM) reported 0.32 earnings per share (EPS) to beat the analysts' consensus estimate of 0.31 by 0.01. Learn more on analysts' earnings estimate vs. BSEM's actual earnings. How can I listen to BioStem Technologies's earnings conference call? The conference call for BioStem Technologies's latest earnings report can be listened to online. Listen to Conference Call How can I read BioStem Technologies's conference call transcript? The conference call transcript for BioStem Technologies's latest earnings report can be read online. Read Transcript How much revenue does BioStem Technologies generate each year? BioStem Technologies (OTCMKTS:BSEM) has a recorded annual revenue of $16.68 million. What is BioStem Technologies's price-to-earnings ratio? BioStem Technologies (OTCMKTS:BSEM) has a trailing price-to-earnings ratio of 17.70 and a forward price-to-earnings ratio of 8.54. What is BioStem Technologies's EPS forecast for next year? BioStem Technologies's earnings are expected to grow from 1.41 per share to 2.29 per share in the next year, which is a 62.41% increase. ` More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! This page (OTCMKTS:BSEM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
